首页|期刊导航|Pharmacoeconomics and Policy|Pharmacoeconomic evaluation for Chinese medicine products:Progress,challenges,and suggestions

Pharmacoeconomic evaluation for Chinese medicine products:Progress,challenges,and suggestionsOA

中文摘要

Pharmacoeconomic evaluation is essential for integrating Chinese medicine products into health systems.Despite notable progress in research output and quality over the past decade,methodological challenges remain,such as a lack of high-quality clinical evidence,outcome measures specific to Chinese medicine products,inappropriate study duration choices,scientific justification for selecting comparators,accurate calculation of costs and benefits,and tailored evaluation methods for Chinese medicine products.We suggest incorporating economic evaluations within randomized controlled trials(RCTs)of innovative products and conducting cost-effectiveness analyses of established therapies using real-world data(RWD).These strategies will help develop evidence-based frameworks specific to Chinese medicine products and strengthen the global foundation of pharmacoeconomics for herbal medicines,promoting their integration into health systems and clinical practice.

Yunfeng Lai;Dongning Yao;Hao Hu

School of Public Health and Management,Guangzhou University of Chinese Medicine,Guangzhou,510006,ChinaSchool of Pharmacy,Nanjing Medical University,Nanjing,211166,ChinaState Key Laboratory of Mechanism and Quality Research of Chinese Medicine,Institute of Chinese Medical Sciences,University of Macao,Macao SAR,999078,China Centre for Pharmaceutical Regulatory Sciences,University of Macao,Macao SAR,999078,China Department of Public Health and Medicinal Administration,Faculty of Health Sciences,University of Macao,Macao SAR,999078,China

医药卫生

PharmacoeconomicsChinesemedicineHerbalmedicineCost-effectivenessanalysisCost-utilityanalysisReal-worlddata

《Pharmacoeconomics and Policy》 2026 (2)

P.69-76,8

supported by the grants from the Science and Technology Development Fund(Fundo para o Desenvolvimento das Ciências e da Tecnologia,FDCT)Macao SAR,China(File No.:0002/2025/NRP)the Guangdong Federation of Social Sciences 2025 Traditional Chinese Medicine Humanities and Social Sciences Research Project,China(Grant No.:SKL25ZY10)the Humanities and Social Sciences Cultivation Project of Guangzhou University of Chinese Medicine,China(Grant No.:2024ZDPY02)the University-Hospital Joint Fund Project of Guangzhou University of Chinese Medicine,China(Grant No.:GZYZS2024G34)the Guangdong Provincial Education Science Planning Project,China(Grant No.:2025GXJK0050)Youth Innovative Talents Project of Ordinary Universities in Guangdong Province in 2025,China(Grant No.:2025WQNCX010).

10.1016/j.pharp.2026.06.001

评论